Arcadis reports transactions under its current share buyback program
3 February 2021 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, has repurchased 48,787 of its own shares in the period from 27 January 2021 up to and including 2 February 2021 at an average price of €28.66. The consideration of this repurchase was €1.4 million. The repurchase is in accordance with the share buyback program to cover obligations from employee incentive plans, as announced on 30 December 2020.
The total number of shares repurchased under this program to date is 388,155 shares for a total consideration of €11.3 million.
For more detailed information see: https://www.arcadis.com/en/global/investors/share-information/share-buyback-program/
For further information please contact:
Arcadis Investor Relations
Mobile: +31 6 51599483
Arcadis is a leading global Design & Consultancy organization for natural and built assets. Applying our deep market sector insights and collective design, consultancy, engineering, project and management services we work in partnership with our clients to deliver exceptional and sustainable outcomes throughout the lifecycle of their natural and built assets. We are 28,000 people, active in over 70 countries that generate €3.5 billion in revenues. We support UN-Habitat with knowledge and expertise to improve the quality of life in rapidly growing cities around the world. www.arcadis.com.
This press release contains information that qualifies or may qualify as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
- Arcadis reports transactions under its current share buyback program week 5
- 2021 Arcadis Share Buyback program week 5
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Junshi Biosciences26.2.2021 18:37:02 CET | Press release
U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy
F. Hoffmann-La Roche Ltd26.2.2021 18:31:32 CET | Press release
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany
Pro Kapital Grupp26.2.2021 18:01:31 CET | Press release
Pro Kapital Council approved Consolidated Interim Report for IV Quarter and 12 Months of 2020 (Unaudited)
Cargotec Corporation26.2.2021 17:41:40 CET | Press release
Cargotec Corporation: Share Repurchase 26.2.2021
Leasinvest Real Estate Comm. VA26.2.2021 17:41:29 CET | Press release
Leasinvest Real Estate SCA sells the semi-industrial part of the Brixton Business Park in Zaventem
International Petroleum Corporation26.2.2021 17:31:29 CET | Press release
International Petroleum Corporation Announces Updated Share Capital
Ress Life Investments A/S26.2.2021 17:06:25 CET | Press release
Ress Life Investments A/S: Ress Life Investments A/S publishes Net Asset Value (NAV)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom